These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28242659)

  • 1. Molecular Confirmation of the Relationship between Candida guilliermondii Fks1p Naturally Occurring Amino Acid Substitutions and Its Intrinsic Reduced Echinocandin Susceptibility.
    Dudiuk C; Macedo D; Leonardelli F; Theill L; Cabeza MS; Gamarra S; Garcia-Effron G
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242659
    [No Abstract]   [Full Text] [Related]  

  • 2. A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibility.
    Garcia-Effron G; Katiyar SK; Park S; Edlind TD; Perlin DS
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2305-12. PubMed ID: 18443110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Fks hot spot for acquired echinocandin resistance in Saccharomyces cerevisiae and its contribution to intrinsic resistance of Scedosporium species.
    Johnson ME; Katiyar SK; Edlind TD
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3774-81. PubMed ID: 21576441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates.
    Park S; Kelly R; Kahn JN; Robles J; Hsu MJ; Register E; Li W; Vyas V; Fan H; Abruzzo G; Flattery A; Gill C; Chrebet G; Parent SA; Kurtz M; Teppler H; Douglas CM; Perlin DS
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3264-73. PubMed ID: 16048935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Echinocandin resistance in Candida species: mechanisms of reduced susceptibility and therapeutic approaches.
    Beyda ND; Lewis RE; Garey KW
    Ann Pharmacother; 2012; 46(7-8):1086-96. PubMed ID: 22811350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris.
    Kordalewska M; Lee A; Park S; Berrio I; Chowdhary A; Zhao Y; Perlin DS
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632013
    [No Abstract]   [Full Text] [Related]  

  • 7. Role for Fks1 in the intrinsic echinocandin resistance of Fusarium solani as evidenced by hybrid expression in Saccharomyces cerevisiae.
    Katiyar SK; Edlind TD
    Antimicrob Agents Chemother; 2009 May; 53(5):1772-8. PubMed ID: 19258277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to echinocandin-class antifungal drugs.
    Perlin DS
    Drug Resist Updat; 2007 Jun; 10(3):121-30. PubMed ID: 17569573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of FKS Gene in the Susceptibility of Pathogenic Fungi to Echinocandins.
    Hori Y; Shibuya K
    Med Mycol J; 2018; 59(2):E31-E40. PubMed ID: 29848909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-beta-D-glucan synthase: implication for the existing susceptibility breakpoint.
    Garcia-Effron G; Lee S; Park S; Cleary JD; Perlin DS
    Antimicrob Agents Chemother; 2009 Sep; 53(9):3690-9. PubMed ID: 19546367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of L701 M mutation in the FKS1 gene of echinocandin-susceptible Candida krusei isolates.
    Lallitto F; Prigitano A; Mangione F; Piralla A; Tamarozzi F; Marone P; Cavanna C
    Diagn Microbiol Infect Dis; 2018 Dec; 92(4):311-314. PubMed ID: 30131237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated chitin content reduces the susceptibility of Candida species to caspofungin.
    Walker LA; Gow NA; Munro CA
    Antimicrob Agents Chemother; 2013 Jan; 57(1):146-54. PubMed ID: 23089748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal resistance does not necessarily affect Candida glabrata fitness.
    Borghi E; Andreoni S; Cirasola D; Ricucci V; Sciota R; Morace G
    J Chemother; 2014 Feb; 26(1):32-6. PubMed ID: 24091025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequencing of
    Arrieta-Aguirre I; Menéndez-Manjón P; Cuétara MS; Fernández de Larrinoa I; García-Ruiz JC; Moragues MD
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29229638
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical perspectives on echinocandin resistance among Candida species.
    Shields RK; Nguyen MH; Clancy CJ
    Curr Opin Infect Dis; 2015 Dec; 28(6):514-22. PubMed ID: 26524326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolutionary accumulation of
    Tian S; Wu Y; Li H; Rong C; Wu N; Chu Y; Jiang N; Zhang J; Shang H
    Emerg Microbes Infect; 2024 Dec; 13(1):2377584. PubMed ID: 38989545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candida lusitaniae MICs to the echinocandins are elevated but FKS-mediated resistance is rare.
    Lockhart SR; Pham CD; Kuykendall RJ; Bolden CB; Cleveland AA
    Diagn Microbiol Infect Dis; 2016 Jan; 84(1):52-54. PubMed ID: 26429293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Echinocandin-Induced Microevolution of Candida parapsilosis Influences Virulence and Abiotic Stress Tolerance.
    Papp C; Kocsis K; Tóth R; Bodai L; Willis JR; Ksiezopolska E; Lozoya-Pérez NE; Vágvölgyi C; Mora Montes H; Gabaldón T; Nosanchuk JD; Gácser A
    mSphere; 2018 Nov; 3(6):. PubMed ID: 30429225
    [No Abstract]   [Full Text] [Related]  

  • 19. Implication of Candida parapsilosis FKS1 and FKS2 mutations in reduced echinocandin susceptibility.
    Martí-Carrizosa M; Sánchez-Reus F; March F; Cantón E; Coll P
    Antimicrob Agents Chemother; 2015; 59(6):3570-3. PubMed ID: 25779577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positions and numbers of FKS mutations in Candida albicans selectively influence in vitro and in vivo susceptibilities to echinocandin treatment.
    Lackner M; Tscherner M; Schaller M; Kuchler K; Mair C; Sartori B; Istel F; Arendrup MC; Lass-Flörl C
    Antimicrob Agents Chemother; 2014 Jul; 58(7):3626-35. PubMed ID: 24733467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.